Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough? – Authors' reply

Michael A. Davies; Philippe Saiag; Georgina V. Long

doi:10.1016/S1470-2045(17)30640-X

Primary medical therapy for BRAF^V600E-mutant melanoma brain metastases—is this good enough? – Authors' reply

Michael A. Davies, Philippe Saiag, Georgina V. Long

Melanoma Medical Oncology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	e509
Journal	The lancet oncology
Volume	18
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(17)30640-X
State	Published - Sep 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(17)30640-X

Cite this

@article{83bdbaa0f9b94c9cbd81ca6a4f046ee2,

title = "Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough? – Authors' reply",

author = "Davies, {Michael A.} and Philippe Saiag and Long, {Georgina V.}",

year = "2017",

month = sep,

doi = "10.1016/S1470-2045(17)30640-X",

language = "English (US)",

volume = "18",

pages = "e509",

journal = "The lancet oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough? – Authors' reply

AU - Davies, Michael A.

AU - Saiag, Philippe

AU - Long, Georgina V.

PY - 2017/9

Y1 - 2017/9

UR - http://www.scopus.com/inward/record.url?scp=85040514896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040514896&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(17)30640-X

DO - 10.1016/S1470-2045(17)30640-X

M3 - Letter

C2 - 28884697

AN - SCOPUS:85040514896

SN - 1470-2045

VL - 18

SP - e509

JO - The lancet oncology

JF - The lancet oncology

IS - 9

ER -

Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough? – Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Primary medical therapy for BRAF^V600E-mutant melanoma brain metastases—is this good enough? – Authors' reply